跳至主要内容
临床试验/IRCT20240622062210N1
IRCT20240622062210N1招募中3 期

Investigating the effectiveness of propolis as an adjuvant treatment for the eradication of Helicobacter pylori: Double-blind randomized controlled clinical trial

Oroumia University of Medical Sciences0 个研究点目标入组 66 人开始时间: 待定最近更新:
适应症

试验速览

阶段
3 期
状态
招募中
发起方
入组人数
66

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 60 years(—)
性别
All

入选标准

  • Patients aged 18-60 years old
  • Helicobacter pylori infected patients

排除标准

  • Chronic diseases such as diabetes, CKD, Malignancy, gallbladder disorders, peptic ulcer and upper gastrointestinal surgery
  • Consumption of propolis or other antioxidant supplements or herbal drugs over the past 3 months
  • allergy to propolis

研究者

发起方
Oroumia University of Medical Sciences

相似试验

propolis supplementation for the eradication of... | 临床试验